Last reviewed · How we verify
Placebo (for Diazoxide)
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation. Used for Control arm in clinical trials evaluating diazoxide efficacy.
At a glance
| Generic name | Placebo (for Diazoxide) |
|---|---|
| Also known as | Placebo |
| Sponsor | Albert Einstein College of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials. Any observed effects result from the placebo effect—a psychobiological phenomenon where patient expectations, conditioning, and the clinical context influence symptom perception and outcomes. In this case, it serves as a control comparator for diazoxide efficacy studies.
Approved indications
- Control arm in clinical trials evaluating diazoxide efficacy
Common side effects
Key clinical trials
- Effect of Insulin Lowering on Lipogenesis (PHASE1)
- Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) (PHASE4)
- Regulation of Endogenous Glucose Production by Central KATP Channels (PHASE2)
- Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period (PHASE3)
- A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome (PHASE3)
- The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients (PHASE2)
- Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression? (PHASE1, PHASE2)
- Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Diazoxide) CI brief — competitive landscape report
- Placebo (for Diazoxide) updates RSS · CI watch RSS
- Albert Einstein College of Medicine portfolio CI